Neoplasm of Lung: Clinical Trials

1 trial for Neoplasm of Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Neoplasm of Lung: new trials by email Literature Review of Neoplasm of Lung trials Research Report on Neoplasm of Lung

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
9-ING-41 in Patients With Advanced Cancers
9-ING-41, Gemcitabine - 21 day cycle, Doxorubicin. - Cancer, Pancreatic Cancer
Phase 2Active not recruitingActuate Therapeutics Inc.3502019-01-042026-04-03

Narrower conditions

Bone Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Glioma (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Kidney Neoplasms (1)  ·  Leukemia-Lymphoma, Adult T-Cell (1)  ·  Lung Neoplasms (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)

Broader conditions

Bone Diseases (1)  ·  Breast Diseases (1)  ·  Colonic Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Genetic Diseases, Inborn (1)  ·  Hematologic Diseases (1)

Interventions

3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Carboplatin (1)  ·  Doxorubicin (1)  ·  Gemcitabine (1)  ·  Irinotecan (1)  ·  Lomustine (1)  ·  Paclitaxel (1)  ·  Taxes (1)  ·  liposomal doxorubicin (1)

Sponsors

Actuate Therapeutics Inc. (1)

Countries

Belgium (1)  ·  Canada (1)  ·  France (1)  ·  Netherlands (1)  ·  Portugal (1)  ·  Spain (1)  ·  United States (1)

Results publications

PMID 24327518, PMID 27424289, PMID 28053024, PMID 28672195, PMID 29383130, PMID 29846250, PMID 30405781, PMID 30975030, PMID 31101621, PMID 31401903, PMID 31533931, PMID 31831767, PMID 31882719, PMID 31894292, PMID 35815408, PMID 41981308